MML Strategic Emerging Markets Fund LSE:AZN Holdings History
MML Strategic Emerging Markets Fund's AstraZeneca PLC Holding Summary
As of 2025-03-31, MML Series Investment Fund II held 4,499.00 shares of AstraZeneca PLC(LSE:AZN), totaling £657,500.00. This investment constitutes 1.63% of their stock portfolio, and MML Series Investment Fund II now holds 0% of the outstanding AstraZeneca PLC(LSE:AZN) stock.
The initial trade took place in 2024Q1. And since then MML Strategic Emerging Markets Fund has made 4 purchases of LSE:AZN, at an average price of £106.98, for a total of 7,137.00 shares. In addition, there have been 1 sales at an average price of £114.13 for 2,638.00 shares. Based on historical transaction data and LSE:AZN's current price of £102.94, MML Strategic Emerging Markets Fund's estimated gain on his LSE:AZN holdings is £674.56, reflecting a 0.09% gain to date.
MML Strategic Emerging Markets Fund LSE:AZN (£102.94) Holding Chart
MML Strategic Emerging Markets Fund LSE:AZN (£102.94) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price £-/Share | ||
| Shares Sold | 0 | Average Price £-/Share | ||
| Current Price £0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
